The Effects of Antipsychotics on Prolactin Levels and Women's Menstruation
- PMID: 24490071
- PMCID: PMC3886401
- DOI: 10.1155/2013/502697
The Effects of Antipsychotics on Prolactin Levels and Women's Menstruation
Abstract
Introduction. Typical and atypical antipsychotic agent is currently used for treatment in the majority of patients with psychotic disorders. The aim of this review is to assess antipsychotic induced hyperprolactinaemia and the following menstrual dysfunction that affects fertility, quality of life, and therapeutic compliance of women. Method. For this purpose, Medline, PsychInfo, Cochrane library, and Scopus databases were accessed, with a focus on the publication dates between 1954 and 2012. Research of references was also performed and 78 studies were retrieved and used for the needs of this review. Results. A summary of several antipsychotics as well as frequency rates and data on hyperprolactinaemia and menstrual disorders for different agent is presented. Conclusion. Diverse prevalence rates of hyperprolactinaemia and menstrual abnormalities have been found about each medication among different studies. Menstruation plays an important role for women, thus, understanding, careful assessment, and management of hyperprolactinaemia could enhance their lives, especially when dealing with women that suffer from a psychotic disorder.
Figures
References
-
- Dickson RA, Glazer WM. Neuroleptic-induced hyperprolactinaemia. Schizophrenia Research. 1999;(35):575–586. - PubMed
-
- Peuskens J, Sienaert P, de Hert M. Sexual dysfunction: the unspoken side effect of antipsychotics. European Psychiatry. 1998;13(1):23–30. - PubMed
-
- Knegtering H, van der Moolen AEGM, Castelein S, Kluiter H, van den Bosch RJ. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology. 2003;28(2):109–123. - PubMed
-
- Canuso CM, Goldstein JM, Wojcik J, et al. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Research. 2002;111(1):11–20. - PubMed
-
- Brunelleschi S, Zeppegno P, Risso F, Cattaneo CI, Torre E. Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients. Pharmacological Research. 2003;48(4):405–409. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
